Indoles and their fused analogues are ubiquitous structural scaffolds present in a plethora of bioactive natural products and pharmaceutical compounds, showcasing their importance in drug design and delivery. Since the discovery of isocyanide-based multicomponent reactions (IMCRs), especially the Ugi reaction, there has been exponential growth in the development of new methodologies based on the post-modification of the Ugi reaction. This has led to the creation of diverse heterocyclic scaffolds, macromolecules, and natural products. This review summarizes the progression of Ugi-multicomponent reactions (MCRs) and their post-modification methods from 2012 to mid-2024. It highlights the documented protocols for constructing various indoles and hetero-fused indole derivatives in an enantioselective, regioselective, and chemoselective manner, emphasising their significance for medicinal chemists.
No takes yet. Share an insight, caveat, or question.
Kalhans et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: